Buys
Open market- Shares
- Avg price
- Total value
Jennifer J. Rhodes - EVP, CHIEF LEGAL OFFICER, SEC at ACADIA PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Evp, Chief Legal Officer, Sec
- Issuer ticker
- ACAD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Jennifer J. Rhodes in ACADIA PHARMACEUTICALS INC
Sells
Open market- Shares
- -10,794
- Avg price
- $22.70
- Total value
- -$245,022
Net
Past year- Shares
- -10,794
- Share %
- -100%
- Total value
- -$245,022
Reported holdings for Jennifer J. Rhodes in ACADIA PHARMACEUTICALS INC
Form 4 holding
EVP, CHIEF LEGAL OFFICER, SEC
ACADIA PHARMACEUTICALS INC
- Security class
- Restricted Stock Units
- Shares / value
- 22,547
- Estimated value
- $548,030
- Report date
- 24 Mar 2026
- Price
- $18.23
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, CHIEF LEGAL OFFICER, SEC
ACADIA PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 11,280
- Estimated value
- $242,181
- Report date
- 25 Mar 2026
- Price
- $21.47
- Ownership
- Direct
Form 4 holding
EVP, CHIEF LEGAL OFFICER, SEC
ACADIA PHARMACEUTICALS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 90,691
- Estimated value
- Report date
- 06 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jennifer J. Rhodes in ACADIA PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.